A pilot study of the in vitro antimicrobial activity and in vivo residual activity of chlorhexidine and acetic acid/boric acid impregnated cleansing wipes
- PMID: 31666075
- PMCID: PMC6820967
- DOI: 10.1186/s12917-019-2098-z
A pilot study of the in vitro antimicrobial activity and in vivo residual activity of chlorhexidine and acetic acid/boric acid impregnated cleansing wipes
Abstract
Background: Topical antimicrobials are recommended for first line treatment of surface and superficial infections in dogs. This is especially important given the increasing prevalence of antimicrobial resistant infections. Antimicrobial wipes have become popular, but there are a lack of controlled studies assessing their in vitro antimicrobial and in vivo residual activity. We aimed to assess the antimicrobial efficacy of two commercial antimicrobial wipes against frequently isolated pathogens. Ten clinical and one reference isolate each of meticillin-susceptible Staphylococcus pseudintermedius (MSSP), meticillin-resistant S. pseudintermedius (MRSP), Escherichia coli (EC), extended spectrum beta-lactamase (ESBL) producing E. coli (ESBL-EC), Pseudomonas aeruginosa (PA) and Malassezia pachydermatis (MP) were tested using a modified Kirby-Bauer technique. Each isolate was tested against 6 mm discs of chlorhexidine (CHX) and acetic acid/boric acid (AABA) wipes, and positive and negative controls either overnight (bacteria) or for 3 days (Malassezia). Healthy dogs were treated with the wipes and distilled water on a randomised flank (n = 5 each). Hair samples (1 cm; 0.1 g) taken at days 0, 1 and 3 were inoculated with an isolate of each organism. Zones of inhibition (ZI) were measured.
Results: All isolates produced confluent growth with AABA and control wipes, except for the cleansing wipes and MP (median ZI 12 mm; 95% CI 8.2-15.8). The median (95% CI) CHX wipe ZIs (mm) were: MP 48.0 (47.0-49.0), MSSP 15.6 (14.2-17.0), MRSP 14.0 (13.6-14.4), EC 13.6 (12.0-15.2) and ESBL-EC 10.0 (9.4-10.6). PA showed confluent growth. The differences between the bacterial isolates was significant (Kruskal-Wallis p < 0.0001; post-tests MSSP = MRSP = EC > EBSL-EC > PA). Confluent growth was visible with all the hair samples.
Conclusion: CHX but not AABA showed in vitro efficacy against MSSP, MRSP, EC and MP. ESBL-EC were less susceptible and there was no activity against PA. There was no residual activity on hair. Additional studies are required to determine efficacy of these products in clinically affected patients.
Keywords: Acetic acid; Antimicrobial wipe; Boric acid; Chlorhexidine; Cutaneous; Dog; Microbial infection; Topical.
Conflict of interest statement
TJ Nuttall and VH Robinson have received unrelated support and/or funding from ICF® and Dechra® Veterinary Products but the companies were not involved in the funding or the design of the study, and the authors have no financial or other interests in their products.
The other authors report no competing interests.
Similar articles
-
Comparative in vitro efficacy of antimicrobial shampoos: a pilot study.Vet Dermatol. 2012 Feb;23(1):36-40, e8. doi: 10.1111/j.1365-3164.2011.01002.x. Epub 2011 Jul 21. Vet Dermatol. 2012. PMID: 21777309
-
A pilot study comparing in vitro efficacy of topical preparations against veterinary pathogens.Vet Dermatol. 2016 Jun;27(3):152-e39. doi: 10.1111/vde.12306. Epub 2016 Apr 24. Vet Dermatol. 2016. PMID: 27109449
-
In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs.Vet Dermatol. 2012 Dec;23(6):493-e95. doi: 10.1111/j.1365-3164.2012.01095.x. Epub 2012 Oct 11. Vet Dermatol. 2012. PMID: 23050904
-
Antimicrobial resistance in methicillin susceptible and methicillin resistant Staphylococcus pseudintermedius of canine origin: literature review from 1980 to 2013.Vet Microbiol. 2014 Jul 16;171(3-4):337-41. doi: 10.1016/j.vetmic.2014.02.008. Epub 2014 Feb 18. Vet Microbiol. 2014. PMID: 24613081 Review.
-
Canine superficial bacterial folliculitis: current understanding of its etiology, diagnosis and treatment.Vet J. 2014 Feb;199(2):217-22. doi: 10.1016/j.tvjl.2013.11.014. Epub 2013 Nov 23. Vet J. 2014. PMID: 24345778 Review.
Cited by
-
In Vitro Effect of Eucalyptus Essential Oils and Antiseptics (Chlorhexidine Gluconate and Povidone-Iodine) against Bacterial Isolates from Equine Wounds.Vet Sci. 2023 Dec 26;11(1):12. doi: 10.3390/vetsci11010012. Vet Sci. 2023. PMID: 38250918 Free PMC article.
-
Efficacy of Chlorhexidine Impregnated Wipes for the Local Dysbiosis in Atopic Dogs: A Multicentric Prospective Study.Vet Sci. 2024 May 27;11(6):240. doi: 10.3390/vetsci11060240. Vet Sci. 2024. PMID: 38921987 Free PMC article.
-
Performance of Daily Pads Containing Ophytrium and Chlorhexidine Digluconate 3% in Dogs With Local Cutaneous Bacterial and/or Malassezia Overgrowth.Front Vet Sci. 2021 May 7;8:579074. doi: 10.3389/fvets.2021.579074. eCollection 2021. Front Vet Sci. 2021. PMID: 34026882 Free PMC article.
-
Effect on Cellular Vitality In Vitro of Novel APRF-Chlorhexidine Treated Membranes.J Funct Biomater. 2022 Nov 7;13(4):226. doi: 10.3390/jfb13040226. J Funct Biomater. 2022. PMID: 36412868 Free PMC article.
-
Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID).Vet Dermatol. 2025 Jun;36(3):234-282. doi: 10.1111/vde.13342. Vet Dermatol. 2025. PMID: 40338805 Free PMC article.
References
-
- Hillier A, Lloyd DH, Weese JS, Blondeau JM, Boothe D, Breitschwerdt E, Guardabassi L, Papich M, Rankin S, Turnidge JD, Sykes JE. Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (antimicrobial guidelines working Group of the International Society for companion animal infectious diseases) Vet Dermatol. 2014;25:163–e43. doi: 10.1111/vde.12118. - DOI - PubMed
-
- Cavana P, Peano A, Petit J-Y, Tizzabi P, Perrot S, Bensignor E, Guillot J. A pilot study of the efficacy of wipes containing chlorhexidine 0.3%, climbazole 0.5% and Tris-EDTA to reduce Malassezia pachydermatis populations on canine skin. Vet Dermatol. 2015;26:278–e261. doi: 10.1111/vde.12220. - DOI - PMC - PubMed
-
- Devriese LA, Vancanneyt M, Baele M, Vaneechoutte M, De Graef E, Snauwaert C, Cleenwerck I, Dawyndt P, Swings J, Decostere A, Haesebrouck F. Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int J Syst Evol Microbiol. 2005;55:1569–1573. doi: 10.1099/ijs.0.63413-0. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases